Literature DB >> 19242095

The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.

Michaela S Banck1, Side Li, Hitomi Nishio, Cheng Wang, Andreas S Beutler, Martin J Walsh.   

Abstract

The zinc finger protein 217 (ZNF217) is an important oncogene based on the high frequency of amplification and overexpression in many cancer types, but its molecular mode of gene regulation is poorly understood. We purified a complex of nuclear ZNF217-binding proteins by affinity chromatography and identified its components by mass spectrometry as Jarid1b/Plu-1, G9a, LSD1, CoREST and CtBP1. Individual binding of these with ZNF217 was confirmed by co-immunoprecipiation (IP). Known activities of these proteins suggested a role of the ZNF217 complex in histone modification. Using in vitro assays the following activities were demonstrated: Histone H3 lysine 4 trimethyl (H3K4me3) demethylase activity, which co-fractionated with Jarid1b/Plu-1 in anion-exchange chromatography; H3K9 methylation, the known principal activity of G9a; and H3K27 methylation. The latter suggested EZH2 as another ZNF217 binding candidate, which could be confirmed by co-IP. Taken together, these findings suggest that ZNF217 assembles a distinct set of histone modifying proteins at target DNA sites that act synergistically in transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242095      PMCID: PMC2929765          DOI: 10.4161/epi.4.2.7953

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  32 in total

Review 1.  The coregulator exchange in transcriptional functions of nuclear receptors.

Authors:  C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

2.  A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes.

Authors:  Mohamed-Ali Hakimi; Daniel A Bochar; Josh Chenoweth; William S Lane; Gail Mandel; Ramin Shiekhattar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 3.  The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer?

Authors:  William R Sellers; Massimo Loda
Journal:  Cancer Cell       Date:  2002-11       Impact factor: 31.743

4.  Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3.

Authors:  M Tachibana; K Sugimoto; T Fukushima; Y Shinkai
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

5.  PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?

Authors:  Angela Barrett; Bente Madsen; John Copier; Pei Juan Lu; Lucienne Cooper; Angelo G Scibetta; Joy Burchell; Joyce Taylor-Papadimitriou
Journal:  Int J Cancer       Date:  2002-10-20       Impact factor: 7.396

6.  Applicability of tandem affinity purification MudPIT to pathway proteomics in yeast.

Authors:  Johannes Graumann; Leslie A Dunipace; Jae Hong Seol; W Hayes McDonald; John R Yates; Barbara J Wold; Raymond J Deshaies
Journal:  Mol Cell Proteomics       Date:  2003-12-05       Impact factor: 5.911

7.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

8.  Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.

Authors:  Gobi Thillainadesan; Majdina Isovic; Esther Loney; Joseph Andrews; Marc Tini; Joseph Torchia
Journal:  Mol Cell Biol       Date:  2008-07-14       Impact factor: 4.272

9.  CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription.

Authors:  Hitomi Nishio; Martin J Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205

10.  A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.

Authors:  Mohamed-Ali Hakimi; Yuanshu Dong; William S Lane; David W Speicher; Ramin Shiekhattar
Journal:  J Biol Chem       Date:  2002-12-18       Impact factor: 5.157

View more
  39 in total

1.  The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.

Authors:  Laurie E Littlepage; Adam S Adler; Hosein Kouros-Mehr; Guiqing Huang; Jonathan Chou; Sheryl R Krig; Obi L Griffith; James E Korkola; Kun Qu; Devon A Lawson; Qing Xue; Mark D Sternlicht; Gerrit J P Dijkgraaf; Paul Yaswen; Hope S Rugo; Colleen A Sweeney; Colin C Collins; Joe W Gray; Howard Y Chang; Zena Werb
Journal:  Cancer Discov       Date:  2012-05-10       Impact factor: 39.397

Review 2.  Biology and Treatment of Rhabdoid Tumor.

Authors:  James I Geller; Jacquelyn J Roth; Jaclyn A Biegel
Journal:  Crit Rev Oncog       Date:  2015

3.  Epigenetic markers in basal cell carcinoma: universal themes in oncogenesis and tumor stratification? - a short report.

Authors:  Rajesh C Rao; May P Chan; Chris A Andrews; Alon Kahana
Journal:  Cell Oncol (Dordr)       Date:  2018-09-13       Impact factor: 6.730

Review 4.  H3K9 methyltransferase G9a and the related molecule GLP.

Authors:  Yoichi Shinkai; Makoto Tachibana
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

5.  The multi-zinc finger protein ZNF217 contacts DNA through a two-finger domain.

Authors:  Noelia Nunez; Molly M K Clifton; Alister P W Funnell; Crisbel Artuz; Samantha Hallal; Kate G R Quinlan; Josep Font; Marylène Vandevenne; Surya Setiyaputra; Richard C M Pearson; Joel P Mackay; Merlin Crossley
Journal:  J Biol Chem       Date:  2011-09-11       Impact factor: 5.157

6.  Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator.

Authors:  Verena K Maier; Caitlin M Feeney; Jordan E Taylor; Amanda L Creech; Jana W Qiao; Attila Szanto; Partha P Das; Nicholas Chevrier; Catherine Cifuentes-Rojas; Stuart H Orkin; Steven A Carr; Jacob D Jaffe; Philipp Mertins; Jeannie T Lee
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

7.  CHD6 regulates the topological arrangement of the CFTR locus.

Authors:  Ana Sancho; SiDe Li; Thankam Paul; Fan Zhang; Francesca Aguilo; Ajay Vashisht; Natarajan Balasubramaniyan; Neal S Leleiko; Frederick J Suchy; James A Wohlschlegel; Weijia Zhang; Martin J Walsh
Journal:  Hum Mol Genet       Date:  2015-01-28       Impact factor: 6.150

8.  Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.

Authors:  Samantha Gadd; Simone Treiger Sredni; Chiang-Ching Huang; Elizabeth J Perlman
Journal:  Lab Invest       Date:  2010-03-08       Impact factor: 5.662

9.  ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.

Authors:  Aurélie Thollet; Julie A Vendrell; Léa Payen; Sandra E Ghayad; Sabrina Ben Larbi; Evelyne Grisard; Colin Collins; Marie Villedieu; Pascale A Cohen
Journal:  Mol Cancer       Date:  2010-11-08       Impact factor: 27.401

10.  Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.

Authors:  Joseph J Abrajano; Irfan A Qureshi; Solen Gokhan; Deyou Zheng; Aviv Bergman; Mark F Mehler
Journal:  PLoS One       Date:  2009-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.